SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001493152-23-011600
Filing Date
2023-04-07
Accepted
2023-04-07 17:29:53
Documents
11

Document Format Files

Seq Description Document Type Size
1 forms-3.htm S-3 519884
2 ex1-2.htm EX-1.2 411679
3 ex4-3.htm EX-4.3 522156
4 ex5-1.htm EX-5.1 26475
5 ex23-1.htm EX-23.1 4645
6 ex107.htm EX-FILING FEES 116083
7 forms-3_001.jpg GRAPHIC 11726
8 forms-3_002.jpg GRAPHIC 10149
9 ex23-1_001.jpg GRAPHIC 5902
10 ex23-1_002.jpg GRAPHIC 2846
11 GRAPHIC forms-3_003.jpg GRAPHIC 3607
  Complete submission text file 0001493152-23-011600.txt   1649707
Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278 (847) 787-7361
Eton Pharmaceuticals, Inc. (Filer) CIK: 0001710340 (see all company filings)

IRS No.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-271196 | Film No.: 23809300
SIC: 2834 Pharmaceutical Preparations